[Form 4] TRUSTMARK CORP Insider Trading Activity

Rhea-AI Filing Summary

Trustmark Corporation (TRMK): A company director reported selling 8,000 shares of common stock on 11/04/2025 at a weighted average price of $37.215. The filing notes the trades occurred across prices ranging from $37.27 to $37.17.

Following the transaction, the reporting person beneficially owns 13,421 shares directly and 1,500 shares indirectly through a spouse. The direct total includes 32 shares acquired through the TRMK Employee and Director Stock Purchase Plan and 2 shares acquired via dividend reinvestment as of November 1, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conerly Tracy T

(Last) (First) (Middle)

P. O. BOX 291

(Street)

JACKSON MS 39205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRUSTMARK CORP [ TRMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2025		S		8,000	D	$37.215(1)	13,421(2)	D
Common Stock								1,500	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.27 to $37.17, inclusive. The reporting person undertakes to provide to Trustmark Corporation, any security holder of Trustmark Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form.

2. Includes 32 shares acquired through TRMK Employee and Director Stock Purchase Plan and 2 shares acquired through dividend reinvestment plan as of November 1, 2025.

	Tracy T. Conerly by Granville Tate, Jr., POA	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for TRMK?

A director sold 8,000 shares of common stock on 11/04/2025 at a weighted average price of $37.215.

What price range were the TRMK shares sold at?

The sales occurred at prices ranging from $37.27 to $37.17, inclusive.

How many TRMK shares does the reporting person now hold directly?

The reporting person now holds 13,421 shares directly.

Does the reporting person have any indirect TRMK holdings?

Yes. There are 1,500 shares held indirectly, reported as By Spouse.

What plans contributed to the direct share total for TRMK?

The direct total includes 32 shares via the Employee and Director Stock Purchase Plan and 2 shares via dividend reinvestment as of November 1, 2025.

What is the filer’s relationship to TRMK?

The reporting person is a Director and filed as one reporting person.